The anthrapyrazoles

被引：18

作者：

Gogas, H ^{[1
]}

Mansi, JL ^{[1
]}

机构：

[1] ST GEORGE HOSP,DEPT ONCOL,LONDON SW17 0QT,ENGLAND

来源：

CANCER TREATMENT REVIEWS | 1995年 / 21卷 / 06期

关键词：

D O I：

10.1016/0305-7372(95)90017-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：541 / 552

页数：12

共 55 条

[1] PHASE-I STUDY OF THE ANTHRAPYRAZOLE BIANTRAZOLE - CLINICAL-RESULTS AND PHARMACOLOGY [J].

ALLAN, SG ;

CUMMINGS, J ;

EVANS, S ;

NICOLSON, M ;

STEWART, ME ;

CASSIDY, J ;

SOUKOP, M ;

KAYE, SB ;

SMYTH, JF .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (01) :55-58

[2]

ALLEGRA JC, 1985, INVEST NEW DRUG, V3, P153

[3] PHASE-II EVALUATION OF PIROXANTRONE IN RENAL-CELL CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

ALLEN, A ;

WOLF, M ;

CRAWFORD, ED ;

DAVIS, MP ;

NATALE, RB ;

BARNETT, ML .

INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) :129-132

[4]

AMES M, 1990, CANCER RES, V50, P3906

[5] PHASE-I PHARMACOKINETIC STUDY OF DUP-937, A NEW ANTHRAPYRAZOLE [J].

BELANGER, K ;

JOLIVET, J ;

MAROUN, J ;

STEWART, D ;

GRILLOLOPEZ, A ;

WHITFIELD, L ;

WAINMAN, N ;

EISENHAUER, E .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) :301-308

[6]

BERG SL, 1993, CANCER RES, V53, P2587

[7]

BURCHENAL JH, 1985, P AM ASSOC CANC RES, V26, P224

[8]

CALVERT H, 1994, P AN M AM SOC CLIN, V13, P71

[9] PHASE-II STUDY OF TAXOL, MERBARONE, AND PIROXANTRONE IN STAGE-IV NON-SMALL-CELL LUNG-CANCER - THE EASTERN COOPERATIVE ONCOLOGY GROUP RESULTS [J].

CHANG, AY ;

KIM, K ;

GLICK, J ;

ANDERSON, T ;

KARP, D ;

JOHNSON, D .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :388-394

[10] PATTERNS OF CROSS-RESISTANCE IN A MULTIDRUG-RESISTANT SMALL-CELL LUNG-CARCINOMA CELL-LINE [J].

COLE, SPC .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (04) :250-256

← 1 2 3 4 5 6 →